Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment
Prophylaxis has been established as the treatment of choice in children with haemophilia and its continuation into the adult years has been shown to decrease morbidity throughout life. The cost of factor therapy has made the option questionable in cost-ef
|Collections||ANU Research Publications|
|01_Farrugia_Treatment_for_life_for_severe_2013.pdf||307.43 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.